Press Releases

Intec Pharma Announces Closing of $35.4 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the closing of its previously announced offering of 6.75 million of its ordinary shares, at a public offering price of $5.25 per ordinary... read more →

April 13, 2018
Insight
Press Releases

Intec Pharma Announces Pricing of $35.4 Million Public Offering of Ordinary Shares

Intec Pharma Ltd. (NASDAQ and TASE: NTEC) today announced the pricing of an underwritten public offering of 6.75 million of its ordinary shares at a public offering price of $5.25per ordinary... read more →

April 11, 2018
Insight
Press Releases

Intec Pharma (Nasdaq: NTEC) to Ring The Nasdaq Stock Market Closing Bell

Intec Pharma Ltd. (Nasdaq:NTEC), a biopharmaceutical company developing a treatment for Parkinson’s disease symptoms in advanced Parkinson’s disease patients, will visit the Nasdaq MarketSite in Times Square in observance of... read more →

April 10, 2018
Insight
Press Releases